Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Annals of the New York Academy of Sciences|November 1, 2003
Agonist-induced transitions of the acetylcholine receptorRobert H Fairclough, Mark A Agius, Eswari Gudipati, et al.Archives of Neurology|December 14, 2011
Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changesDavid P Richman, Kayoko Nishi, Stuart W Morell, et al.Muscle & Nerve|July 4, 2019
Validation of the triple timed up-and-go test in Lambert-Eaton myastheniaShruti M Raja, Donald B Sanders, Vern C Juel, et al.Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.BMJ Open|September 19, 2020
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North AmericaJoshua D Green, Richard J Barohn, Emanuela Bartoccion, et al.Pageof 3